According to a new report Asia-Pacific Implantable Medical Devices Market, published by KBV Research, the Asia-Pacific Implantable Medical Devices is expected grow at a CAGR of 8.6% during the forecast period. The China market dominated the Asia-Pacific Metal Implantable Medical Devices Market by Country in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 4.1% during the forecast period. The India market is expected to witness a CAGR of 8.5% during (2016 - 2022). Additionally,
The South Korea market is expected to witness a CAGR of 7.8% during (2016 - 2022). The Orthopedic Implants market dominated the China Implantable Medical Devices Market by Product in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 6.5 % during the forecast period. The Cardiovascular Implants market is expected to witness a CAGR of 5.5% during (2016 - 2022). Additionally, The Dental Implants market is expected to witness highest CAGR of 6.5% during (2016 - 2022). The Reconstructive joint replacements market dominated the China Implantable Medical Devices Market by Orthopedic Implants in 2015, and would continue to be a dominant market till 2022.
The Knee Replacements market is expected to witness a CAGR of 9.6% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Asia-PacificImplantable Medical Devices have been discussed in the report along with the elaborated company profiles of Abbott Laboratories., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson, Medtronic Plc, Smith And Nephew Plc, Stryker Corporation, C.R. Bard, Inc., Cardinal health, Inc. and Globus Medical, Inc.
Full report : https://www.kbvresearch.com/asia-pacific-implantable-medical-devices-market/
Research Scope
Global Implantable Medical Devices Market
North America Implantable Medical Devices Market
Unique Offerings 
